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Background: Promotion of healthy pregnancies has gained high priority in the Netherlands because of relatively
unfavorable perinatal outcomes. In response, a nationwide study, ‘Healthy Pregnancy 4 All’ (HP4ALL), has been
initiated. Part of this study involves systematic and broadened antenatal risk assessment (the Risk Assessment
substudy). Risk selection in current clinical practice is mainly based on medical risk factors. Despite the increasing
evidence for the influence of nonmedical risk factors (social status, lifestyle or ethnicity) on perinatal outcomes,
these risk factors remain highly unexposed. Systematic risk selection, combined with customized care pathways to
reduce or treat detected risks, and regular and structured consultation between community midwives,
gynecologists and other care providers such as social workers, is part of this study.
Methods/Design: Neighborhoods in 14 municipalities with adverse perinatal outcomes above national and
municipal averages are selected for participation. The study concerns a cluster randomized controlled trial.
Municipalities are randomly allocated to intervention (n = 3,500 pregnant women) and control groups (n = 3,500
pregnant women). The intervention consists of systematic risk selection with the Rotterdam Reproductive Risk
Reduction (R4U) score card in pregnant women at the booking visit, and referral to corresponding care pathways.
A risk score, based on weighed risk factors derived from the R4U, above a predefined threshold determines
structured multidisciplinary consultation. Primary outcomes of this trial are dysmaturity (birth weight < p10),
prematurity (birth <37 weeks), and efficacy of implementation.
Discussion: The ‘HP4ALL’ study introduces a systematic approach in antenatal health care that may improve
perinatal outcomes and, thereby, affect future health status of a new generation in the Netherlands.
Trial registration: Dutch Trial Registry (NTR-3367) on 20 March 2012.
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Perinatal mortality rates in the Netherlands are higher
than in other European countries and are showing a
slower rate of decline [1]. The latest confirmed statistics
describe a perinatal mortality rate (deaths from 22 weeks
of gestation up to 7 days postpartum) of 8.5 per 1,000
births [2]. In addition, higher risks for adverse outcomes
were found for women living in socioeconomically de-
prived areas, particularly in the four largest cities in the
Netherlands [3]. The adverse perinatal health outcome
in the Netherlands has triggered debates and initiatives
to study and intervene in possible causes for these ad-
verse outcomes.
More than 85 percent of all causes of perinatal mortal-
ity in the Netherlands are associated with four adverse
perinatal outcomes, namely congenital disorders, small
for gestational age (birth weight <10th percentile for ges-
tational age), premature delivery (birth <37 weeks), and/
or a suboptimal start at birth (Apgar score <7 after
5 minutes); these are defined as the ‘Big 4’ outcomes [4].
Poor outcomes were especially observed in deprived dis-
tricts and are often associated with socioeconomic and
ethnicity related risk factors such as low education, low in-
come and poor integration into society [5,6].
The Dutch system
The Dutch antenatal healthcare system is divided into
three levels of care in which a distinction is made between
low-risk and high-risk pregnancies. The primary level of
care, antenatal health care is provided by independently
practicing midwives who deliver care to pregnant women
with an uncomplicated pregnancy, childbirth and the
postpartum period. These women are estimated to be ‘low
risk’. If complications (threaten to) occur, midwives refer
the women to a gynecologist at the secondary level of care
[7]. The tertiary level of care takes place in centers for
perinatology with a neonatal intensive care unit and an
obstetric ‘high-care’ department. The latter is reserved for
severely ill women or threatened pregnancies [8].
Current practice of risk selection
Current risk selection during the antenatal period fo-
cuses on medical risk factors [9,10]. A list of obstetric
indications, for which referral from primary to secondary
care is prescribed, has been composed by professionals
involved in the field. On this list, the most frequently oc-
curring medical conditions and prior obstetric complica-
tions are allocated to the different levels of care. The
composition of this list was based on best evidence or
best practices. Since the last update in 2003, there has
been an increase in evidence of the influence of non-
medical risk factors (social status, lifestyle or ethnicity)
on adverse perinatal outcomes [11]. These risk factors
are usually not considered in current risk screeningpractices. Moreover, it was shown that an accumulation
of these risk factors can even further harm the chances
of a good pregnancy outcome. This phenomenon implies
that the presence of a number of smaller risk factors, ra-
ther than a single greater one, increases the risk on ad-
verse perinatal outcomes [4,11,12].Initiatives to improve perinatal health
To improve perinatal health, especially in socially de-
prived districts, the Rotterdam municipal council and
health scientists of the Erasmus University Medical Centre
initiated a city-wide perinatal health program ‘Ready for
Baby’ in 2009 [5]. The ‘Ready for Baby’ program provided
the framework for this national study. It was within this
program that scorecard-based risk screening and corre-
sponding care pathways were developed and piloted.
Within the context of this program, the Rotterdam area
served as a testing ground for a number of experi-
ments, including the development and piloting of the
R4U (Rotterdam Reproductive Risk Reduction) scorecard
for antenatal risk screening [13]. These former experi-
ences were used to further improve and implement these
tools in other municipalities with high perinatal mortality
and morbidity in the Healthy Pregnancy 4 All study. The
Healthy Pregnancy 4 All study was launched in 2011 by
the Erasmus University Medical Centre in 14 municipal-
ities in the Netherlands. It focuses on preconception care
and broadened risk selection during pregnancy [14].
In the risk assessment substudy, we will implement
and investigate the Rotterdam Reproductive Risk Reduc-
tion (R4U) scorecard, corresponding care pathways and
multidisciplinary consultation. This score card focuses
on both medical and nonmedical risk factors, including
psychological, social, lifestyle, obstetric and nonobstetric
care-related risks. During the first antenatal visit, the R4U
scorecard will be assessed by a midwife or gynecologist.
The aim of this study is to investigate the effectiveness
of this new approach in antenatal health care on peri-
natal outcomes.Methods/Design
Outline
The study design concerns a cluster randomized con-
trolled trial at the municipality level. Selected municipal-
ities are randomly allocated to intervention and control
groups. The intervention comprises systematic risk se-
lection with the R4U scorecard in pregnant women at
the booking visit and referral to the corresponding care
pathways. A risk score, based on weighed risk factors
derived from the R4U, above a predefined threshold
determines consultation among community midwives,
gynecologists, and other care providers, such as social
workers in a multidisciplinary setting.
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tematic approach in antenatal health care on adverse preg-
nancy outcomes (primarily lowering prematurity and
small for gestational age outcomes) and 2) the efficacy of
implementation (measured by the number of R4Us filled
out by the healthcare professional, the performance of
multidisciplinary deliberations and patient and healthcare
professional satisfaction).
Participants/eligibility criteria
The selection of neighborhoods is based on the presence
of an elevated incidence of adverse perinatal outcomes
(above both the national and municipal average). Muni-
cipalities are extracted after a selection process in which
zip codes with high adverse perinatal outcomes are iden-
tified in a thorough analysis. For this analysis, data from
all singleton pregnancies in the Netherlands over the
period of 2000 to 2008 were obtained with permission
from the Dutch Perinatal Registry (PRN) [15]. The de-
tailed selection process of the municipalities and geo-
graphical areas are described elsewhere [14].
All midwives and gynecologists providing care to women
living in these zip codes will be invited to participate in the
Healthy Pregnancy 4 All study. All pregnant women living
in these selected areas are eligible for this trial. All munici-
palities deal with an above-average perinatal mortality rate
and many disadvantaged neighborhoods. Exclusion criteria
include an acute obstetric situation during the booking
visit (for example, ectopic pregnancy) and women in labor
during this initial visit.
Study design
To prevent contamination, we have randomized on the
level of municipalities instead of (1) on the level of mid-
wife practices or (2) on the level of hospitals or obstetric
collaborations.
Randomization at the level of the individual patient is
not possible because of contamination to a healthcare pro-
fessional: a care provider will not be able to distinguish be-
tween intervention and control participants within their
practice.
Many midwife practices are cooperating with hospitals
in so-called obstetric collaborations (OC’s). Randomization
on the level of OC’s was also not an option: hospitals
are always involved in one particular OC, but midwife
practices can participate in more than one OC. This is
especially the case in municipalities with more than one
hospital.
Intervention and control
Use of the R4U scorecard, corresponding care path-
ways, and multidisciplinary consultation will be compared
with conventional antenatal health care. In municipal-
ities allocated to the intervention group, midwives andgynecologists will use the R4U scorecard during every first
antenatal visit (provided that informed consent is given).
The R4U scorecard consists of six domains (social status,
ethnicity, care, lifestyle, medical history and obstetric his-
tory), subdivided into 70 items. The R4U scorecard is pro-
posed to facilitate improved coordination of antenatal care
through systematic and uniform risk screening for medical
and nonmedical risk factors. A risk score, based on risk
factors derived from the R4U, above the predefined cut-off
point implies follow-up action. This follow-up action in-
cludes multidisciplinary consultation between obstetric
caregivers and nonobstetric caregivers (for example, social
workers) and prioritization of risk factors. For each cluster,
this cut-off point will be calculated after a pilot of 50 R4U
scorecards have been completed in a municipality. We
strive to assess 20% of all pregnant women in this multi-
disciplinary setting. Healthcare professionals determine
when and how to organize these meetings, with a mini-
mum frequency of once a month. A standardized format
is available to discuss a patient in such meetings. The pur-
pose of these meetings is to assess a customized antenatal
policy for each individual pregnant woman.
We developed 28 templates of care pathways for all
risk factors incorporated in the R4U score card. Care
pathways consist of steps a caregiver could follow to
meet specific needs for pregnant women. Together with
local healthcare professionals from both the perinatal
care, community health services (called the GGD), and
other services, these templates will be adapted to local
circumstances. Local facilities, agreements, and guidelines
will be incorporated. Depending on local availability, care
pathways will developed for all items as presented in the
R4U scorecard. These created care pathways will support
the individual healthcare professional to encounter com-
plex (non-) medical risk factors. They can also facilitate
the collaboration among different healthcare professionals
and professionals within the community health services.
Pregnant women in the control group will receive con-
ventional antenatal health care. After the inclusion of
700 participants or after two-thirds of our study period
(2 years), we will end the control group in a particular
municipality and will start with the implementation of
the R4U scorecard and corresponding care pathways. As
mentioned in our introduction, several studies revealed a
disadvantaged position of the Netherlands regarding peri-
natal mortality. For the first time, the unique organization
of antenatal care in the Netherlands was openly ques-
tioned. In response, health care professionals and policy
makers were urged to undertake interventions. The fact
that we made municipalities aware of their perinatal
health statistics and allocated them to be ‘a control’ was
contradictory to ambitions to intervene, as the control sta-
tus was felt to be the negligent attitude of local health
authorities.
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opportunity to start with the intervention after they have
reached a certain amount of included subjects or at two-
thirds of the way through the study. Therefore, we aim
to implement and facilitate this new approach in all 14
municipalities at the end of the study period. This im-
plies that the study design remains a parallel trial in
which only pregnancy outcomes from regular antenatal
health care in control municipalities will be analyzed.
Pregnancy outcomes of women enrolled after the ‘cross-
over’ in control municipalities (that is, women in control
municipalities that were exposed the intervention) will
not be analyzed for this purpose.
Procedures, recruitment, randomization, and collection of
baseline data
Randomization took place in January 2011 by an inde-
pendent statistician who was not involved in executing
the study. In order to decide whether matching was ne-
cessary, in each cluster, the adverse perinatal outcomes
(Big 4 and perinatal mortality) were stratified according to
socioeconomic status and ethnicity. Since clusters were
not considerably different in terms of these characteristics,
we decided that matching of clusters for socio-economic
status and ethnicity was unnecessary.
As stated before, midwife practices participate in OC’s.
Due to merging plans between OC’s in the north of the
Netherlands, four small municipalities and one large
municipality were combined and form one cluster
(named Groningen). Thus, ten municipalities were ran-
domly assigned to the intervention (n = 5) or the control
group (n = 5).
In the randomization procedure, municipalities were
numbered according to the expected number at risk.
Hereby, we ensured that both arms of the experiment were
comparable in size. Five random numbers were drawn
from the uniform distribution between zero and one. If the
number was below 0.5, the first of the pair would be
assigned to the intervention, otherwise to the control
group. The clusters Amsterdam, Tilburg, Groningen,
Enschede and Nijmegen are allocated as intervention
municipalities. The clusters for The Hague, Schiedam,
Heerlen, Almere and Utrecht are control municipalities.
The randomization scheme is available as an additional
file (see Additional file 1).
The logistics are carried out in close collaboration with
participating local program coordinators, midwives, gy-
necologists, and, if available, research midwives in the 14
participating municipalities. Eligible women will receive
participant information, and they will be asked for written
consent to collect data on their pregnancy outcomes by
the participating healthcare professionals. These health-
care professionals will register all participating women an-
onymously by a study number in a web-based database.We will ask to register the 4-digit zip code, maternal age,
gestational age at booking visit, and certain items of the
obstetric history. All women participating in the risk
assessment study within the HP4ALL study will receive
either one or two questionnaires. The first questionnaire
contains questions regarding baseline characteristics, such
as marital status, household composition and income, edu-
cation level, ethnicity, lifestyle (smoking, alcohol, and drug
use), use of folic acid, medical history, and use of medica-
tion. This questionnaire will be completed around the first
antenatal visit (depending on local logistics). The second
questionnaire focuses on satisfaction. In this questionnaire,
we will investigate patient satisfaction regarding their first
antenatal visit. We compare satisfaction in participants in
the intervention group with participants receiving conven-
tional antenatal health care. This questionnaire will be
completed by a selection of study participants. We will ask
all participating practices/hospitals to distribute this ques-
tionnaire in a predefined time period of 3 months to all
study participants having their third antenatal visit. This
visit is before the so-called 20-week ultrasound. With this
timing, we try to avoid bias in answering the questionnaire
due to outcomes resulting from this ultrasound.
To provide baseline characteristics from participating
healthcare professionals, an interview will be performed
with one healthcare professional from each participating
midwifery practice and hospital. In this structured inter-
view, we will collect data on the number of patients and
employees, the current use of risk-selection instruments,
collaboration with hospitals and (other) midwifery prac-
tices in OC’s, and work processes in their antenatal health-
care (for example, counseling for prenatal screening, or
ultrasound facilities). This will be repeated at the end of
the study. We will use the Relational Coordination survey
to measure the coordination performance of healthcare
professionals. Gittell’s theory of Relational Coordination
has been developed for measuring coordination perform-
ance among different professions. The healthcare profes-
sionals will be surveyed about their communication and
relationships with other healthcare professionals during
the antenatal phase. This will allow us to observe the effect
of our intervention on the coordination performance of
healthcare professionals [16]. Table 1 provides an overview
of the planned assessments within the risk assessment
substudy including variables, methods and outcomes.
Outcome
The primary outcomes are small for gestational age, pre-
term birth, and efficacy of implementation. Small for
gestational age is defined as birth weight below the 10th
percentile for gestational age. Preterm birth is defined as
birth before 37 weeks of gestation.
Efficacy of implementation will be measured by the
number of R4Us completed by the healthcare professional




Nonmedical risk factors: 39 items from the risk scorecard,
categorized into the domains of social, ethnicity, care,
and lifestyle.




- Small for gestational age
Medical risk factors: 30 items from the risk scorecard,




Secondary outcomes - Undetected small for
gestational age and unexpected preterm births
(babies born in the first level of care)
Baseline characteristics: Age, zip code, ethnicity, onset of
care, household composition, family income, employment,
education level, smoking, alcohol, drugs, folic acid use,
medication use, pre-existing chronic diseases, and
sexually transmitted diseases.
Case Record Form ‘pregnancy
and delivery data’
- Prevalence of risk factors
- Risk accumulation
- Involved healthcare professionals during pregnancy
- Detection and prevention of impaired growth




- Place of delivery
2. CONTROL GROUP
Baseline characteristics: Age, zip code, ethnicity, onset of
care, household composition, family income, employment,
education level, smoking, alcohol, drugs, folic acid use,
medication use, pre-existing chronic diseases, and
sexually transmitted diseases.
Registration form ‘Obstetric history’ - Asphyxia
Questionnaire ‘Baseline
characteristics’ Case Record Form
‘pregnancy and delivery data’
- Neonatal admission
- Maternal morbidity (such as pre-existing chronic
disease, pregnancy complications, positive booking
bloods), and maternal mortality.
Patient satisfaction in both groups Questionnaire ‘Patient experiences
during the first antenatal visit’
- Which topics were discussed (10 examples)?
- What was your experience?
- Do you think this was important to ask?
Care providers
Variables Methods Outcomes
General characteristics participating midwives
practices and hospitals in both groups
Interview-based questionnaire - Current status number of patients and employees
- Use of risk selection instruments
- Collaboration with hospitals and (other) midwifery
practices
- Work processes (for example, counseling for
prenatal screening, or ultrasound facilities)
Care provider satisfaction in both groups Questionnaire - Feasibility
- Efficacy of implementation
- Collaboration
- Continuation of intervention
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and use of care pathways, actual performed multidisciplin-
ary consultations, and patient and healthcare professional
satisfaction. Primary outcomes, except for patient satisfac-
tion, will be recorded by healthcare professionals or the
project team after delivery on case record forms in an
electronic database.
Secondary outcomes are perinatal mortality (from
the 22th week of gestation until 7 days postpartum),undetected small for gestational age and unexpected
preterm births (babies born in the first level of care),
and prevalence and accumulation of medical and non-
medical risk factors.
Other outcome parameters are: detection and prevention
of impaired growth and preterm birth during pregnancy,
delivery modus, place of delivery, involved healthcare pro-
fessionals, congenital anomalies, neonatal admission, as-
phyxia, maternal morbidity (such as pre-existing chronic
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bloods) and maternal mortality.
Follow-up
The follow-up period consists of 6 weeks. Details of
pregnancy, delivery, and maternal follow-up will be re-
corded after 6 weeks in a case record form. If necessary,




The sample size is determined by focusing on the pri-
mary objective of the trial: the effectiveness of systematic
antenatal screening on adverse small for gestational age
(<10th percentile) and preterm birth (gestational age
below 37 weeks). In this cluster-randomized trial, sample
size depends on (1) the average risk of small for gesta-
tional age and preterm birth without the intervention
(π0); (2) the expected effect of the intervention (π1); (3)
the inflation factor reflecting the partial similarity/
dependency of women’s outcomes or responses within the
same cluster; (4) the α; and (5) power (1-β) of the test.
Based on data from the Dutch perinatal registry [15],
the average prevalence in our selected zip code areas in
the years 2000 to 2008 was 16.7%. In the intervention
group, we expect a prevalence of 13% at the end of the
study period. The average prevalence of both primary
outcomes in the Netherlands was 12% for the years 2000
to 2008 [15], and we expect a decline towards this preva-
lence during our study period. The inflation factor was
estimated to be 2.06 [17]. This factor reflects the design
effect of a cluster trial, and takes into account the degree
of similarity among responses within a cluster. With
five municipalities in each group (a total of ten clus-
ters) and an alpha of 0.05 (two-sided test), 7,000 partici-
pants (3,500 per arm) should provide power in excess of
80%. This means 700 women are needed per cluster. It is
assumed that a difference of 150 to 200 participants be-
tween the larger and smaller clusters has no implications
for the outcome [17].
Data analysis
Data will be analyzed according to the intention-to-treat
principle. The effectiveness of the R4U scorecard, corre-
sponding care pathways and multidisciplinary consultation
versus conventional antenatal healthcare (measured as the
difference in small for gestational age and preterm birth
between both groups) will be assessed by using multilevel
logistic regression with random effects. Results will be
presented as effect estimates with a measure of precision
(95% confidence interval). Data will be analyzed anonym-
ously on two levels: the maternal and the municipal level.
To guarantee anonymity, we will not analyze the data oncommunity practice or at the hospital level. Study par-
ticipants, municipalities, and community practices or
hospitals will not be traceable. Other analyses related to
our intervention are based on differences in other birth
outcomes (for example, Apgar score), the number of refer-
rals between community midwives and gynecologists,
adequacy in risk assessment (for example, detection of
growth restriction in the antenatal phase), and the contri-
bution of nonmedical risk factors to adverse birth out-
comes between the intervention and control group. These
outcomes will be assessed with univariate and multivariate
regression analysis with 95% confidence intervals.Ethical considerations
This study has been approved by the Ethics Committee of
the Erasmus Medical Center Rotterdam (Ref. No. MEC-
2012-322) and by the management of participating hospi-
tals that requested an extra review (see Additional file 2).
All participants will receive written and oral informa-
tion about the study, after which informed consent will
be obtained. Participation is voluntary and no extra in-
centives will be provided.Discussion
The main objective of this trial is to investigate the effective-
ness of a new systematic approach in antenatal healthcare
on adverse pregnancy outcomes and efficacy of implemen-
tation. We will implement and investigate the Rotterdam
Reproductive Risk Reduction (R4U) scorecard and corre-
sponding care pathways in 14 municipalities.
The study meets the current evidence to intervene
early in pregnancy upon (modifiable) risk factors associ-
ated with adverse perinatal health outcomes. We aim to
target a population that potentially will benefit the most
with the use of selected geographical areas. With the use
of care pathways, optimal linkage is sought between
curative and preventive care, such as public health, gov-
ernment, and social welfare organizations [14].
To our knowledge, this is the first approach in ante-
natal healthcare whereby systematic risk selection for both
medical and nonmedical risk factors, variable thresholds,
tailor-made care pathways, and structured consultation
between midwives, gynecologists and other care providers
are combined. This study will introduce a systematic ap-
proach in antenatal health care, which may improve peri-
natal outcomes and, thereby, future health status of a new
generation in the Netherlands.Trial status
Recruitment started in August 2012, and the first in-
cluded study participant delivered in March 2013. The
trial is currently recruiting study participants.
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